XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Statements of Cash Flows - USD ($)
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,785,058) $ (3,126,811)
Adjustments to reconcile net loss to net cash used in operating activities    
Preferred shares issued as compensation 11,632 14,408
Common shares issued as compensation and for services 38,250 45,750
Warrants granted to Scientific Advisory Board 135 229
Depreciation 130,752 193,546
Amortization 2,068 2,067
Changes in operating assets and liabilities:    
Prepaid expenses (14,709) (2,391)
Other assets 358 4,409
Accounts payable (57,301) 336,594
Accounts payable - related parties 79,687 (83,489)
Accrued expenses 331 20,825
NET CASH USED IN OPERATING ACTIVITIES (1,593,855) (2,594,863)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (84,317) (46,764)
NET CASH USED IN INVESTING ACTIVITIES (84,317) (46,764)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from sale of common stock 1,245,319 1,710,138
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,245,319 1,710,138
NET CHANGE IN CASH AND CASH EQUIVALENTS (432,853) (931,489)
Cash and cash equivalents at beginning of period 1,558,564 4,797,778
Cash and cash equivalents at end of period 1,125,711 $ 3,866,289
NON CASH FINANCING AND INVESTING ACTIVITIES:    
Issuance of common stock for services rendered $ 146,850